Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Embryonal Tumor With Abundant Neuropil and True Rosettes”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00911560
What this trial is testing

Bivalent Vaccine With Escalating Doses of the Immunological Adjuvant OPT-821, in Combination With Oral β-glucan for High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 374
Testing effectiveness (Phase 2)Looking for participantsNCT06540963
What this trial is testing

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

Who this might be right for
Neuroblastoma
Giselle Sholler 98
Not applicableLooking for participantsNCT05890781
What this trial is testing

Engineering Immune Organoids to Study Pediatric Cancer

Who this might be right for
Brain TumorKidney TumorNeuroblastoma+1 more
Gustave Roussy, Cancer Campus, Grand Paris 108
Testing effectiveness (Phase 2)Study completedNCT00073983
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma

Who this might be right for
Sarcoma
Sarcoma Alliance for Research through Collaboration 54
Large-scale testing (Phase 3)Not Yet RecruitingNCT07291102
What this trial is testing

Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma

Who this might be right for
Medulloblastoma
Nationwide Children's Hospital 96
Not applicableUnknownNCT05755295
What this trial is testing

Horse Therapy for Children, Adolescents and Young Adults in Remission From Medulloblastoma

Who this might be right for
Neuroblastoma
University Hospital, Toulouse 15
Not applicableLooking for participantsNCT01109394
What this trial is testing

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

Who this might be right for
SarcomaEndocrine TumorsNeuroblastoma+2 more
National Cancer Institute (NCI) 6,035
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT00054405
What this trial is testing

Interleukin-12 and Interleukin-2 in Treating Patients With Refractory or Recurrent Neuroblastoma

Who this might be right for
Recurrent Neuroblastoma
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT01175356
What this trial is testing

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

Who this might be right for
GanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+3 more
Children's Oncology Group 99
Not applicableActive Not RecruitingNCT04087902
What this trial is testing

Long-Term Longitudinal QoL in Patients Undergoing EEA

Who this might be right for
Pituitary TumorMeningiomaRathke Cleft Cysts+5 more
Ohio State University 400
Testing effectiveness (Phase 2)Study completedNCT00002825
What this trial is testing

Docetaxel in Treating Children With Recurrent Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsNeuroblastomaSarcoma
National Cancer Institute (NCI) 20
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Testing effectiveness (Phase 2)Study completedNCT03291080
What this trial is testing

Oral Liquid 13-cis-retinoic Acid (13-CRA)

Who this might be right for
Neuroblastoma
Nova Laboratories Limited 20
Not applicableLooking for participantsNCT01050296
What this trial is testing

Molecular Analysis Of Solid Tumors

Who this might be right for
Pediatric Solid Tumors
St. Jude Children's Research Hospital 1,000
Early research (Phase 1)Study completedNCT04023669
What this trial is testing

Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors

Who this might be right for
Brain TumorBrain Tumor, RecurrentBrain Tumor, Refractory+10 more
St. Jude Children's Research Hospital 21
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableStudy completedNCT00904241
What this trial is testing

Biomarkers in Tumor Tissue Samples From Patients With Newly Diagnosed Neuroblastoma or Ganglioneuroblastoma

Who this might be right for
GanglioneuroblastomaLocalized Resectable NeuroblastomaLocalized Unresectable Neuroblastoma+3 more
Children's Oncology Group 10,000
Early research (Phase 1)UnknownNCT01381822
What this trial is testing

Dose-Escalation Study of TH-302 in Combination With Sunitinib to Treat Patients With Advanced Renal Cell Carcinoma,Gastrointestinal Stromal Tumors and Pancreatic Neuroendocrine Tumors

Who this might be right for
Advanced Renal Cell CarcinomaGastrointestinal Stromal TumorsPancreatic Neuroendocrine Tumors
Threshold Pharmaceuticals 58
Early research (Phase 1)Study completedNCT00019019
What this trial is testing

Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more
National Institutes of Health Clinical Center (CC) 70
Next Page